341 related articles for article (PubMed ID: 18727673)
1. Brain atrophy as a marker of cognitive impairment in mildly disabling relapsing-remitting multiple sclerosis.
Sánchez MP; Nieto A; Barroso J; Martín V; Hernández MA
Eur J Neurol; 2008 Oct; 15(10):1091-9. PubMed ID: 18727673
[TBL] [Abstract][Full Text] [Related]
2. Thalamic atrophy predicts cognitive impairment in relapsing remitting multiple sclerosis. Effect on instrumental activities of daily living and employment status.
Papathanasiou A; Messinis L; Zampakis P; Panagiotakis G; Gourzis P; Georgiou V; Papathanasopoulos P
J Neurol Sci; 2015 Nov; 358(1-2):236-42. PubMed ID: 26359854
[TBL] [Abstract][Full Text] [Related]
3. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
4. Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging.
Rovaris M; Iannucci G; Falautano M; Possa F; Martinelli V; Comi G; Filippi M
J Neurol Sci; 2002 Mar; 195(2):103-9. PubMed ID: 11897239
[TBL] [Abstract][Full Text] [Related]
5. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
[TBL] [Abstract][Full Text] [Related]
6. Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis.
Štecková T; Hluštík P; Sládková V; Odstrčil F; Mareš J; Kaňovský P
J Neurol Sci; 2014 Jul; 342(1-2):62-8. PubMed ID: 24819917
[TBL] [Abstract][Full Text] [Related]
7. Cognitive impairment in patients with relapsing-remitting multiple sclerosis. The correlation with MRI lesion volume.
Karlińska I; Siger M; Lewańska M; Selmaj K
Neurol Neurochir Pol; 2008; 42(5):416-23. PubMed ID: 19105110
[TBL] [Abstract][Full Text] [Related]
8. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
[TBL] [Abstract][Full Text] [Related]
9. Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis.
Deloire MS; Salort E; Bonnet M; Arimone Y; Boudineau M; Amieva H; Barroso B; Ouallet JC; Pachai C; Galliaud E; Petry KG; Dousset V; Fabrigoule C; Brochet B
J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):519-26. PubMed ID: 15774439
[TBL] [Abstract][Full Text] [Related]
10. Memory performance in multiple sclerosis patients correlates with central brain atrophy.
Hildebrandt H; Hahn HK; Kraus JA; Schulte-Herbrüggen A; Schwarze B; Schwendemann G
Mult Scler; 2006 Aug; 12(4):428-36. PubMed ID: 16900756
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
Zivadinov R; Sepcic J; Nasuelli D; De Masi R; Bragadin LM; Tommasi MA; Zambito-Marsala S; Moretti R; Bratina A; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
[TBL] [Abstract][Full Text] [Related]
12. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
[TBL] [Abstract][Full Text] [Related]
13. The relationship between regional microstructural abnormalities of the corpus callosum and physical and cognitive disability in relapsing-remitting multiple sclerosis.
Caligiuri ME; Barone S; Cherubini A; Augimeri A; Chiriaco C; Trotta M; Granata A; Filippelli E; Perrotta P; Valentino P; Quattrone A
Neuroimage Clin; 2015; 7():28-33. PubMed ID: 25610764
[TBL] [Abstract][Full Text] [Related]
14. Associations between cognitive and clinical disability across MS subtypes: The role of the underlying brain damage.
Gois LCP; Pimentel-Silva LR; Damasceno BP; Damasceno A
Mult Scler Relat Disord; 2021 Feb; 48():102701. PubMed ID: 33477004
[TBL] [Abstract][Full Text] [Related]
15. Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment.
Amato MP; Bartolozzi ML; Zipoli V; Portaccio E; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
Neurology; 2004 Jul; 63(1):89-93. PubMed ID: 15249616
[TBL] [Abstract][Full Text] [Related]
16. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis.
Dineen RA; Vilisaar J; Hlinka J; Bradshaw CM; Morgan PS; Constantinescu CS; Auer DP
Brain; 2009 Jan; 132(Pt 1):239-49. PubMed ID: 18953055
[TBL] [Abstract][Full Text] [Related]
17. The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.
Yaldizli Ö; Penner IK; Frontzek K; Naegelin Y; Amann M; Papadopoulou A; Sprenger T; Kuhle J; Calabrese P; Radü EW; Kappos L; Gass A
Mult Scler; 2014 Mar; 20(3):356-64. PubMed ID: 23959709
[TBL] [Abstract][Full Text] [Related]
18. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
Amato MP; Portaccio E; Goretti B; Zipoli V; Battaglini M; Bartolozzi ML; Stromillo ML; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
Arch Neurol; 2007 Aug; 64(8):1157-61. PubMed ID: 17698706
[TBL] [Abstract][Full Text] [Related]
19. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis.
Brass SD; Benedict RH; Weinstock-Guttman B; Munschauer F; Bakshi R
Mult Scler; 2006 Aug; 12(4):437-44. PubMed ID: 16900757
[TBL] [Abstract][Full Text] [Related]
20. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]